@article{2983587ffaa9415b81ee5054628108ec,
title = "Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial",
author = "Orin Bloch and Crane, \{Courtney A.\} and Yelena Fuks and Rajwant Kaur and Aghi, \{Manish K.\} and Berger, \{Mitchel S.\} and Butowski, \{Nicholas A.\} and Chang, \{Susan M.\} and Clarke, \{Jennifer L.\} and McDermott, \{Michael W.\} and Prados, \{Michael D.\} and Sloan, \{Andrew E.\} and Bruce, \{Jeffrey N.\} and Parsa, \{Andrew T.\}",
note = "Glioblastoma multiforme (GBM), the most common primary brain malignancy, is associated with a universally poor prognosis. Despite standard treatment with maximal safe surgical resection, conformal radiation, and systemic chemotherapy, the median survival from diagnosis remains 15 months. All patients eventually recur after initial diagnosis and treatment, at which time the median survival is 3-6 months.",
year = "2014",
month = feb,
day = "1",
doi = "10.1093/NEUONC/NOT203",
language = "American English",
volume = "16",
journal = "Neuro-oncology",
}